Nanoviricides Inc (NNVC)
1.17
+0.01
(+0.86%)
USD |
NYAM |
Apr 18, 16:00
1.17
0.00 (0.00%)
After-Hours: 20:00
Nanoviricides Price: 1.17 for April 18, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 17, 2024 | 1.18 | 1.23 | 1.15 | 1.16 | 7733.00 |
Apr 16, 2024 | 1.17 | 1.223 | 1.17 | 1.18 | 8621.00 |
Apr 15, 2024 | 1.250 | 1.29 | 1.13 | 1.15 | 75187.00 |
Apr 12, 2024 | 1.295 | 1.336 | 1.25 | 1.25 | 13594.00 |
Apr 11, 2024 | 1.36 | 1.36 | 1.25 | 1.27 | 24617.00 |
Apr 10, 2024 | 1.35 | 1.41 | 1.28 | 1.31 | 32554.00 |
Apr 09, 2024 | 1.41 | 1.45 | 1.34 | 1.36 | 16711.00 |
Apr 08, 2024 | 1.34 | 1.42 | 1.320 | 1.39 | 35541.00 |
Apr 05, 2024 | 1.38 | 1.48 | 1.31 | 1.37 | 65517.00 |
Apr 04, 2024 | 1.29 | 1.50 | 1.265 | 1.37 | 159443.0 |
Apr 03, 2024 | 1.24 | 1.28 | 1.222 | 1.28 | 10211.00 |
Apr 02, 2024 | 1.19 | 1.30 | 1.19 | 1.27 | 38355.00 |
Apr 01, 2024 | 1.15 | 1.36 | 1.14 | 1.30 | 121239.0 |
Mar 28, 2024 | 1.12 | 1.175 | 1.12 | 1.16 | 23191.00 |
Mar 27, 2024 | 1.13 | 1.135 | 1.12 | 1.13 | 6335.00 |
Mar 26, 2024 | 1.12 | 1.14 | 1.11 | 1.14 | 15268.00 |
Mar 25, 2024 | 1.13 | 1.16 | 1.12 | 1.13 | 18592.00 |
Mar 22, 2024 | 1.16 | 1.16 | 1.12 | 1.14 | 43537.00 |
Mar 21, 2024 | 1.17 | 1.18 | 1.14 | 1.14 | 29317.00 |
Mar 20, 2024 | 1.15 | 1.18 | 1.14 | 1.15 | 43198.00 |
Mar 19, 2024 | 1.14 | 1.20 | 1.14 | 1.15 | 11207.00 |
Mar 18, 2024 | 1.21 | 1.21 | 1.15 | 1.15 | 12262.00 |
Mar 15, 2024 | 1.17 | 1.23 | 1.17 | 1.20 | 34503.00 |
Mar 14, 2024 | 1.152 | 1.17 | 1.14 | 1.17 | 42419.00 |
Mar 13, 2024 | 1.149 | 1.17 | 1.13 | 1.13 | 27485.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.02
Minimum
Nov 27 2023
16.76
Maximum
Jan 31 2020
3.279
Average
2.93
Median
Price Benchmarks
Gilead Sciences Inc | 66.14 |
NovaBay Pharmaceuticals Inc | 0.0821 |
Palatin Technologies Inc | 1.88 |
iBio Inc | 1.78 |
Theriva Biologics Inc | 0.435 |
Price Related Metrics
Price to Book Value | 1.107 |
Earnings Yield | -69.23% |
Market Cap | 13.78M |